We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.25 | 9.00 | 9.50 | 9.25 | 9.25 | 9.25 | 126,038 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.67 | 16.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/3/2018 11:49 | 3 month high. | parob | |
14/3/2018 11:11 | I see someone just completed a quick day trade for £440 profit. Good luck to them but if they held for a few months more then they would probably have made a great deal in excess of that. | rafboy | |
14/3/2018 11:08 | People taking positions following that excellent presentation by the CEO. | rafboy | |
14/3/2018 10:36 | No overhang either watching level 2. Virtually every buy has moved an MM all morning! God knows what would happen if we had any volume! | shrewdmole | |
14/3/2018 10:27 | Agreed and she is very confident and knowledgeable. Great time to buy as the share price will only increase as we near the human trials. | rafboy | |
14/3/2018 10:22 | The fact that companies are approaching Cath is HUGE for me. With her already existing contacts in the industry, once (we hope) the trials prove positive, things will move very fast IMO. | loungeact | |
14/3/2018 09:29 | Nice bit of buying so far today. | rafboy | |
13/3/2018 18:01 | Excellent presentation from Cath. | onedayrodders | |
12/3/2018 19:54 | One of the important aspects we need to remember about SBTX and it's continued relationship UoM, is the fact many of the worlds dermatology companies are already associated in some way to SBTX, via Cath. J&J probably the most well known. Also, as Cath mentioned, some of these companies have approached Cath for advice and wanted to know why she had not been more proactive in contacting them with her work. This should demonstrated the high respect they have for Cath, but also her work. In most cases, this is the hard work in opening commercial doors, these doors have already been opened, so SBTX need to do now, is show the IP works in human trials and let the budding begin. The other aspect she spoke about was the fact cosmetics cannot make any health claims, yet household names are making $bls on the back on the perception they can do x, but they clearly do not. SBTX will clearly have a clear advantage - a good example of this was the boots product. She dropped a clanger with the OPTI market value at £100m.....not quite there yet. I guess she must be thinking TW was right on the money with his valuation. ;) | elrico | |
12/3/2018 19:20 | This Thursday she is doing another presentation, this time in Paris. She has been doing a load of promotions since Feb 20th including one in Amsterdam. This will all equate to more partnering with Bigger Corporates to do the marketing later this year imo. Company CEO Cath O’Neill to showcase SkinBioTherapeutics plc at Pharmabiotics2018 in Paris on March 15th. @Pharmabiotics #SBTX eXCELLENT POST WELL DONE... elrico12 Mar '18 - 15:48 - 1427 of 1428 Latest presentation from CEO Cath O'Neill at Shares Investor Evening in Edinburgh is now available @SHARESmag #SBTX | bobalot | |
12/3/2018 15:53 | Very good presentation. Confident that things will go well for SBTX. It seems our CEO has some excellent contacts and is very aware of the company’s worth following the human trials. | rafboy | |
12/3/2018 15:48 | Latest presentation from CEO Cath O'Neill at Shares Investor Evening in Edinburgh is now available @SHARESmag #SBTX | elrico | |
12/3/2018 14:26 | We both know i'm not filtered :D | loungeact | |
12/3/2018 14:21 | loungeact12 Mar '18 - 13:48 - 1423 of 1423 (Filtered) more of the same rubbish imo. loungeact12 Mar '18 - 14:26 - 1425 of 1425 (Filtered) A COMPULSIVE REPETITIVE DISORDER imo..lol | bobalot | |
12/3/2018 13:48 | You've been through this issue countless times with OPTI holders. OPTI holders will be issued shares as a divi. I know this is difficult for you to accept because you sold all your OPTI shares to invest into SBTX. So, it doesn't really matter what anyone says, you will have your agenda. Your agenda is also clear from your posts on the OPTI BB, where you now bash the company and CEO in an attempt to discredit, hoping investors put their money into SBTX, again to serve your agenda. Also obvious from your ramping here. I think OPTI will reach £1 before much happens here, and I know that must be tough for you somewhat, sitting on a loss right now, but I think SBTX will have it's day. In turn making even more money for OPTI holders - hurts a little doesn't it? :) It's really cute that you can't bring yourself to actually filter me, but you really should and show some integrity for once. Otherwise, you're coming off as really sad. Looking forward to the trials later this year when this thing really gets moving. | loungeact | |
12/3/2018 12:55 | Dear bob, there has been an rns about the sbtx divi and from a credible source. What do you think a 'dividend in specie.' Sbtx is the only company Opti have another holding of a quoted company. OptiBiotix is pleased to announce that, following shareholder approval which was granted on 25 January 2018, the High Court of Justice made an order confirming the Capital Reduction on 27 February 2018. Following the registration of the Court order confirming the Capital Reduction by the Registrar of Companies in England and Wales, the Capital Reduction became effective 27 February 2018. Stephen O'Hara, CEO of OptiBiotix, commented: "I am pleased to report that both shareholders and the Courts have confirmed the capital reduction. This allows OptiBiotix to make future dividend or 'dividend in specie' distributions to the Company's shareholders should it be appropriate to do so. This is part of OptiBiotix's strategy of building value across its divisions and where possible releasing value back to shareholders." ps i'm going to give your post 1404 some coins because i think your lack of knowledge deserves flagging for all visitors because you are dangerous, or would be if people took you seriously. | incanus | |
12/3/2018 12:34 | It is well worth new investors to read articles from reliable sources: SkinBioTherapeutics 'making very good headway' in development of three key programmes Dr Cath O'Neill, chief executive of SkinBioTherapeutics PLC (LON:SBTX), caught up with Proactive's Andrew Scott following the release of the skin-health specialist's interim results. She says they remain on track with the development of their three flagship programmes - in particular the upcoming first human study for the cosmetic application of the compound which is planned for the third quarter of this year. www.proactiveinvesto | bobalot | |
12/3/2018 12:21 | the follow feed doesn't filter people and that really is a pity because you repeat yourself constantly...a real troll imo. | bobalot | |
12/3/2018 12:14 | I see you've taken me off filter or I was just never filtered? :) Lack of integrity I see. You've been through this issue countless times with OPTI holders. OPTI holders will be issued shares as a divi. I know this is difficult for you to accept because you sold all your OPTI shares to invest into SBTX. So, it doesn't really matter what anyone says, you will have your agenda. Your agenda is also clear from your posts on the OPTI BB, where you now bash the company and CEO in an attempt to discredit, hoping investors put their money into SBTX, again to serve your agenda. Also obvious from your ramping here. I think OPTI will reach £1 before much happens here, and I know that must be tough for you somewhat, sitting on a loss right now, but I think SBTX will have it's day. In turn making even more money for OPTI holders - hurts a little doesn't it? :) It's really cute that you can't bring yourself to actually filter me, but you really should and show some integrity for once. Otherwise, you're coming off as really sad. Looking forward to the trials later this year when this thing really gets moving. | loungeact | |
12/3/2018 12:00 | There has never been an RNS about SBTX shares issued as a divi from OPTI...until that happens you are spouting gossip or fake claims. | bobalot | |
12/3/2018 11:56 | Some good ramping there Bob. Personally don't think much will happen until the trials, but I hope i'm wrong. The sooner the better for OPTI holders who are getting free SBTX shares. | loungeact | |
12/3/2018 11:50 | It is highly likely that newsflow will start fairly soon about more patent approvals for China, USA etc after getting a patent approval from Australia recently. Adding yet more value to the share price | bobalot |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions